Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsors and Collaborators: |
Northwestern University Enturia |
---|---|
Information provided by: | Northwestern University |
ClinicalTrials.gov Identifier: | NCT00829023 |
The purpose of the present study was to examine the native bacteria around the shoulder and determine the efficacy of three different surgical skin-preparation solutions on the eradication of bacteria from the shoulder.
Condition | Intervention |
---|---|
Shoulder Surgery |
Other: chlorhexidine gluconate and isopropyl alcohol, iodophor and isopropyl alcohol, povidone-iodine scrub and paint |
Study Type: | Interventional |
Study Design: | Prevention, Randomized, Double Blind (Subject, Outcomes Assessor), Uncontrolled, Parallel Assignment, Efficacy Study |
Official Title: | Efficacy of Surgical Preparation Solutions in Shoulder Surgery |
Enrollment: | 150 |
Study Start Date: | June 2007 |
Study Completion Date: | June 2008 |
Primary Completion Date: | June 2008 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
betadine, DuraPrep, ChloraPrep: Experimental
surgical skin preparation solution
|
Other: chlorhexidine gluconate and isopropyl alcohol, iodophor and isopropyl alcohol, povidone-iodine scrub and paint
surgical skin preparation solutions
|
A prospective study was undertaken to evaluate 150 consecutive patients undergoing shoulder surgery at one institution. Each shoulder was prepared with one of three randomly selected solutions: ChloraPrep (2% chlorhexidine gluconate and 70% isopropyl alcohol), DuraPrep (0.7% iodophor and 74% isopropyl alcohol), or povidone-iodine scrub and paint (0.75% iodine scrub, 1.0% iodine paint). Aerobic and anaerobic cultures were taken prior to skin preparation for the first twenty patients to determine the native bacteria around the shoulder and following skin preparation for all patients.
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
United States, Illinois | |
Northwestern Memorial Hospital | |
Chicago, Illinois, United States, 60611 |
Principal Investigator: | Jason L Koh, MD | Northwestern Memorial Faculty Foundation |
Responsible Party: | Northwestern Memorial Faculty Foundation ( Jason L. Koh, MD ) |
Study ID Numbers: | IRB 1232-008 |
Study First Received: | January 21, 2009 |
Last Updated: | January 23, 2009 |
ClinicalTrials.gov Identifier: | NCT00829023 History of Changes |
Health Authority: | United States: Institutional Review Board |
Positive aerobic or anaerobic cultures |
Anti-Infective Agents Anti-Infective Agents, Local Disinfectants Chlorhexidine Chlorhexidine gluconate |
Povidone Iodine Povidone-Iodine Ethanol |
Anti-Infective Agents Anti-Infective Agents, Local Disinfectants Chlorhexidine Chlorhexidine gluconate |
Therapeutic Uses Povidone-Iodine Dermatologic Agents Pharmacologic Actions |